首页> 外国专利> Pharmaceutical compositions capable of inducing apoptosis in tumour cells, useful for diagnosis and treatment of B-chronic lymphocytic leukaemia

Pharmaceutical compositions capable of inducing apoptosis in tumour cells, useful for diagnosis and treatment of B-chronic lymphocytic leukaemia

机译:能够在肿瘤细胞中诱导细胞凋亡的药物组合物,可用于诊断和治疗B-慢性淋巴细胞性白血病

摘要

The present invention is related to the branch of immunology and particularly with the generation of pharmaceutical compositions comprising a humanized monoclonal antibody recognizing the leukocyte differentiation antigen CD6. Accordingly with that statement, the purpose of this invention is to provide pharmaceutical compositions comprising a humanized anti-CD6 monoclonal antibody for the diagnosis and treatment of Lymphoproliferative Syndromes and particularly the B-Cell Chronic Lymphocytic Leukemia. The essence of the invention consist in the application of a humanized Monoclonal Antibody that recognizes the CD6 antigen, the generation of pharmaceutical compositions comprising that antibody being able to induce apoptosis of malignant cells from B-Cell Chronic Lymphocytic Leukemia patients, reaching a clinical and a histological antitumor efficacy. The field of application of the present invention extends to the Oncology.
机译:本发明涉及免疫学领域,尤其涉及包含识别人白细胞分化抗原CD 6 的人源化单克隆抗体的药物组合物的产生。据此,本发明的目的是提供包含人源化抗CD 6 单克隆抗体的药物组合物,用于诊断和治疗淋巴增生综合征,尤其是B细胞慢性淋巴细胞性白血病。本发明的实质在于识别CD 6 抗原的人源化单克隆抗体的应用,包含该抗体的药物组合物的产生能够诱导来自B细胞慢性淋巴细胞的恶性细胞凋亡。白血病患者,达到了临床和组织学上的抗肿瘤功效。本发明的应用领域扩展到肿瘤学。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号